| 000 | 01788 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517225819.0 | ||
| 264 | 0 | _c20190708 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1873-6815 | ||
| 024 | 7 |
_a10.1016/j.exger.2018.07.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTorosyan, Nare | |
| 245 | 0 | 0 |
_aChanges in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study. _h[electronic resource] |
| 260 |
_bExperimental gerontology _c10 2018 |
||
| 300 |
_a118-121 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
| 650 | 0 | 4 |
_aBrain _xphysiopathology |
| 650 | 0 | 4 | _aBrain Mapping |
| 650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
| 650 | 0 | 4 | _aCognition |
| 650 | 0 | 4 | _aDiet, Ketogenic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKetone Bodies _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 |
_aTriglycerides _xpharmacology |
| 700 | 1 | _aSethanandha, Chakmeedaj | |
| 700 | 1 | _aGrill, Joshua D | |
| 700 | 1 | _aDilley, Michelle L | |
| 700 | 1 | _aLee, Jooyeon | |
| 700 | 1 | _aCummings, Jeffrey L | |
| 700 | 1 | _aOssinalde, Celine | |
| 700 | 1 | _aSilverman, Daniel H | |
| 773 | 0 |
_tExperimental gerontology _gvol. 111 _gp. 118-121 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exger.2018.07.009 _zAvailable from publisher's website |
| 999 |
_c28630604 _d28630604 |
||